Published in Am J Physiol Renal Physiol on November 23, 2011
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res (2013) 1.68
Purinergic signalling in the kidney in health and disease. Purinergic Signal (2013) 0.84
Role of A1 receptors in renal sympathetic neurotransmission in the mouse kidney. Am J Physiol Renal Physiol (2012) 0.82
Role of CD73 in Renal Sympathetic Neurotransmission in the Mouse Kidney. Physiol Rep (2013) 0.79
Interactive roles of CD73 and tissue nonspecific alkaline phosphatase in the renal vascular metabolism of 5'-AMP. Am J Physiol Renal Physiol (2014) 0.79
Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine. Hypertension (2017) 0.75
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem (1996) 10.08
Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol (2006) 7.84
Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension (2007) 5.80
PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol (2004) 5.10
Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci (1990) 4.30
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med (2010) 2.71
From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res (2004) 2.19
Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol (1976) 2.09
Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. J Biol Chem (1993) 1.90
G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci (1998) 1.83
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J (2011) 1.81
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail (2008) 1.38
Subtypes of functional alpha1-adrenoceptor. Cell Mol Life Sci (2009) 1.28
The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail (2007) 1.25
Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res (1978) 1.19
Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol (2003) 1.18
Assessment of nerve stimulation-induced release of purines from mouse kidneys by tandem mass spectrometry. J Pharmacol Exp Ther (2008) 1.17
Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway. Am J Physiol Renal Physiol (2006) 1.16
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol (2007) 1.15
ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exp Ther (2002) 1.11
G protein subunits and the stimulation of phospholipase C by Gs-and Gi-coupled receptors: Lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein. Proc Natl Acad Sci U S A (1996) 1.08
Phospholipase C-beta1 directly accelerates GTP hydrolysis by Galphaq and acceleration is inhibited by Gbeta gamma subunits. J Biol Chem (1999) 1.06
Adenosine A1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens (2003) 1.01
Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension (2008) 1.01
Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem Biophys Res Commun (1997) 0.98
Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int (2006) 0.98
A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go. J Biol Chem (1991) 0.97
Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor. J Med Chem (2000) 0.97
Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther (1991) 0.96
Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension (2008) 0.96
Adenosine A1 receptor antagonists in clinical research and development. Kidney Int (2010) 0.94
Role of G proteins, cyclic AMP, and ion channels in the inhibition of transmitter release by adenosine. Ann N Y Acad Sci (1990) 0.94
Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction. Hypertension (2005) 0.94
P2X receptors as regulators of the renal microvasculature. Trends Pharmacol Sci (2007) 0.93
alpha 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther (2003) 0.92
Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail (2008) 0.91
Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther (2006) 0.91
Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation. Am J Physiol Renal Physiol (2010) 0.91
Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney. Br J Pharmacol (2005) 0.91
Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther (2007) 0.90
Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. Am J Physiol (1987) 0.90
The putative phospholipase C inhibitor U73122 and its negative control, U73343, elicit unexpected effects on the rabbit parietal cell. J Pharmacol Exp Ther (1997) 0.89
Regulation of Na(+)-3HCO3- cotransport in rabbit proximal convoluted tubule via adenosine A1 receptor. Am J Physiol (1993) 0.89
Use of the isolated perfused kidney as a tool in drug disposition studies. Drug Metab Rev (1983) 0.88
P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet. Hypertension (2011) 0.87
Purinoceptors in the kidney. Exp Biol Med (Maywood) (2007) 0.86
Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J Pharmacol Exp Ther (1993) 0.85
Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats. PLoS One (2011) 0.84
An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo. J Pharmacol Exp Ther (1992) 0.83
Adenosine stimulates phosphate and glucose transport in opossum kidney epithelial cells. Am J Physiol (1991) 0.83
Attenuation by alpha,beta-methylenadenosine-5'-triphosphate of periarterial nerve stimulation-induced renal vasoconstriction is not due to desensitization of purinergic receptors. J Pharmacol Exp Ther (1994) 0.82
Mechanism of the vascular angiotensin II/alpha2-adrenoceptor interaction. J Pharmacol Exp Ther (2005) 0.82
Lack of contribution of P2X receptors to neurally mediated vasoconstriction in the rabbit kidney in vivo. Acta Physiol (Oxf) (2006) 0.82
Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert Opin Investig Drugs (2002) 0.81
Effects of alpha- and beta-adrenoceptor blockade on purine secretion induced by sympathetic nerve stimulation in the rat kidney. J Pharmacol Exp Ther (1999) 0.81
Cardiovascular and renal effects of blocking A1 adenosine receptors. J Cardiovasc Pharmacol (1993) 0.80
Increased norepinephrine release during sympathetic nerve stimulation and its inhibition by adenosine in the isolated perfused kidney of spontaneously hypertensive rats. Clin Exp Hypertens A (1983) 0.78
Central effects of caffeine on renal renin secretion and norepinephrine spillover. J Cardiovasc Pharmacol (1996) 0.78
Effects of adenosine on adrenergically induced renal vasoconstriction in dogs. Eur J Pharmacol (1990) 0.77
Role of adenosine in noradrenergic neurotransmission. Am J Physiol (1988) 0.76
Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur J Pharmacol (1981) 0.76
A proteomics approach to understanding protein ubiquitination. Nat Biotechnol (2003) 10.51
Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell (2009) 6.16
Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem (2004) 2.84
Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature (2008) 2.51
Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. J Biol Chem (2005) 2.24
Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell (2010) 2.02
Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem (2008) 1.86
Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol Cell (2010) 1.73
Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood (2013) 1.70
Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J (2006) 1.67
Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase. EMBO J (2006) 1.64
Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem (2004) 1.58
Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem (2011) 1.48
Systematic approach for validating the ubiquitinated proteome. Anal Chem (2008) 1.47
USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1. Mol Cell Biol (2008) 1.44
Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease. J Neurosci (2008) 1.39
Extracellular 2',3'-cAMP is a source of adenosine. J Biol Chem (2009) 1.35
ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs. J Biol Chem (2007) 1.31
Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. J Proteome Res (2009) 1.27
Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol Cell (2008) 1.25
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.23
Huntingtin-associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice. J Clin Invest (2008) 1.19
Cardiovascular pharmacology of estradiol metabolites. J Pharmacol Exp Ther (2003) 1.18
Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol (2002) 1.18
Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol Cell (2005) 1.18
Assessment of nerve stimulation-induced release of purines from mouse kidneys by tandem mass spectrometry. J Pharmacol Exp Ther (2008) 1.17
Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1. J Neurosci (2007) 1.17
Identification and validation of eukaryotic aspartate and glutamate methylation in proteins. J Proteome Res (2008) 1.16
Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics (2010) 1.16
Protein kinase C inhibits autophagy and phosphorylates LC3. Biochem Biophys Res Commun (2010) 1.16
Identification and quantification of 2',3'-cAMP release by the kidney. J Pharmacol Exp Ther (2008) 1.14
Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res (2008) 1.13
Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci (2008) 1.13
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol Dis (2009) 1.11
Complexities of oestradiol pharmacology in pulmonary arterial hypertension. Eur Respir J (2013) 1.11
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Clin Exp Pharmacol Physiol (2008) 1.08
Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice. J Neurotrauma (2010) 1.04
Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. Mol Biol Cell (2008) 1.03
Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther (2003) 1.03
Gender, sex hormones and pulmonary hypertension. Pulm Circ (2013) 1.02
Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol (2013) 1.02
Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension (2008) 1.01
Extracellular cAMP-adenosine pathways in the mouse kidney. Am J Physiol Renal Physiol (2011) 1.00
The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination. J Biol Chem (2014) 0.99
Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions. Biochemistry (2006) 0.99
Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension (2008) 0.96
SOX4 interacts with plakoglobin in a Wnt3a-dependent manner in prostate cancer cells. BMC Cell Biol (2011) 0.95
Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction. Hypertension (2005) 0.94
Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome. Methods Enzymol (2006) 0.94
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma. Oncoimmunology (2012) 0.94
Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth. J Pharmacol Exp Ther (2010) 0.94
Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury. Metabolism (2008) 0.93
Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension. Free Radic Biol Med (2012) 0.93
2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats. J Cardiovasc Pharmacol (2007) 0.93
Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A(2B) receptors. Hypertension (2005) 0.92
Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther (2006) 0.91
Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther (2007) 0.90
The pancreatohepatorenal cAMP-adenosine mechanism. J Pharmacol Exp Ther (2007) 0.90
Characterization of renal ecto-phosphodiesterase. J Pharmacol Exp Ther (2007) 0.89
Extracellular guanosine regulates extracellular adenosine levels. Am J Physiol Cell Physiol (2012) 0.89
The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. J Biol Chem (2012) 0.89
Effect of homomeric P450-P450 complexes on P450 function. Biochem J (2012) 0.88
Identification and characterization of neuronal mitogen-activated protein kinase substrates using a specific phosphomotif antibody. Mol Cell Proteomics (2008) 0.88
The extracellular cAMP-adenosine pathway significantly contributes to the in vivo production of adenosine. J Pharmacol Exp Ther (2006) 0.87
Extracellular 2',3'-cAMP and 3',5'-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cells. Am J Physiol Renal Physiol (2012) 0.87
Proteomic analysis of ubiquitin conjugates in yeast. Methods Enzymol (2005) 0.87
Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats. J Endocrinol (2011) 0.87
Desumoylation of the endoplasmic reticulum membrane VAP family protein Scs2 by Ulp1 and SUMO regulation of the inositol synthesis pathway. Mol Cell Biol (2011) 0.85
Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration. Mol Neurodegener (2011) 0.84
Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
Increased expression of the sodium transporter BSC-1 in spontaneously hypertensive rats. J Pharmacol Exp Ther (2004) 0.83
Association analysis of genomic loci important for grain weight control in elite common wheat varieties cultivated with variable water and fertiliser supply. PLoS One (2013) 0.83
Role of A1 receptors in renal sympathetic neurotransmission in the mouse kidney. Am J Physiol Renal Physiol (2012) 0.82
Regulation of renovascular adenosine 3',5'-cyclic monophosphate in spontaneously hypertensive rats. Hypertension (2009) 0.82
Proteomic analysis of hippocampal dentate granule cells in frontotemporal lobar degeneration: application of laser capture technology. Front Neurol (2011) 0.81
Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-2. Clin Exp Pharmacol Physiol (2007) 0.81
Regulation of renal ectophosphodiesterase by protein kinase C and sodium diet. J Pharmacol Exp Ther (2008) 0.80
Methylation of 2-hydroxyestradiol in isolated organs. Hypertension (2003) 0.79
Moderate hypothermia may be detrimental after traumatic brain injury in fentanyl-anesthetized rats. Crit Care Med (2003) 0.79
Role of CD73 in Renal Sympathetic Neurotransmission in the Mouse Kidney. Physiol Rep (2013) 0.79
Modulation of cyclic AMP production by signal transduction pathways in preglomerular microvessels and microvascular smooth muscle cells. J Pharmacol Exp Ther (2004) 0.78
In vivo cardiovascular pharmacology of 2',3'-cAMP, 2'-AMP, and 3'-AMP in the rat. J Pharmacol Exp Ther (2013) 0.78
Extracellular cyclic AMP-adenosine pathway in isolated adipocytes and adipose tissue. Obes Res (2005) 0.78
Cellular distribution of the renal bumetanide-sensitive Na-K-2Cl cotransporter BSC-1 in the inner stripe of the outer medulla during the development of hypertension in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol (2007) 0.77
PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol. Transpl Int (2007) 0.77
Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats. Eur J Pharmacol (2003) 0.76
A novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesions. Dig Dis Sci (2014) 0.76
Different B-type methionine sulfoxide reductases in Chlamydomonas may protect the alga against high-light, sulfur-depletion, or oxidative stress. J Integr Plant Biol (2013) 0.76
Nitrite Prevents Right Ventricular Failure and Remodeling Induced by Pulmonary Artery Banding. J Cardiovasc Pharmacol (2016) 0.75
Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats. Hypertension (2010) 0.75
Development of a novel adenosine-eluting guidewire (Adenowire) for coronary vasodilation during percutaneous coronary intervention. EuroIntervention (2014) 0.75